NDC 63323-101
Doxorubicin Hydrochloride 2 mg per 1 mL injection, solution
On the label: Fresenius Kabi, LLC.
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Fresenius Kabi USA, LLC | Melrose Park, IL, United States | Makes it | Problems found, fixed voluntarilyAug 24, 2023 · 13 inspections, 2 with FDA action |
Recalls
- Nov 17, 2020 · Class III · Fresenius Kabi USA, LLC
Cross Contamination with Other Products: trace amounts of octreotide found during testing
Lots: Batch: 6120525, exp 11/2020
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Doxorubicin: every company that makes it
- Form
- injection, solution, intravenous
- Strength
- 2 mg per 1 mL
- Approval
- ANDA ANDA063277
- On the market since
- Jun 14, 2000
- Package NDCs
63323-101-61- Official label
- DailyMed (National Library of Medicine), updated Oct 14, 2024
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?